nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—CYP3A4—bone cancer	0.625	1	CbGaD
Eletriptan—HTR1F—trigeminal nerve—bone cancer	0.0214	0.206	CbGeAlD
Eletriptan—HTR1B—dura mater—bone cancer	0.0204	0.196	CbGeAlD
Eletriptan—HTR1D—dura mater—bone cancer	0.0198	0.19	CbGeAlD
Eletriptan—HTR1B—trigeminal nerve—bone cancer	0.00878	0.0843	CbGeAlD
Eletriptan—HTR1D—trigeminal nerve—bone cancer	0.0085	0.0816	CbGeAlD
Eletriptan—HTR1B—cranial nerve—bone cancer	0.00625	0.0601	CbGeAlD
Eletriptan—HTR1D—cranial nerve—bone cancer	0.00605	0.0582	CbGeAlD
Eletriptan—HTR7—cranial nerve—bone cancer	0.00482	0.0463	CbGeAlD
Eletriptan—HTR1D—connective tissue—bone cancer	0.00125	0.012	CbGeAlD
Eletriptan—HTR7—connective tissue—bone cancer	0.000995	0.00956	CbGeAlD
Eletriptan—Clemastine—CYP3A4—bone cancer	0.000982	0.536	CrCbGaD
Eletriptan—HTR1B—spinal cord—bone cancer	0.000855	0.00822	CbGeAlD
Eletriptan—Almotriptan—CYP3A4—bone cancer	0.000852	0.464	CrCbGaD
Eletriptan—HTR2B—tendon—bone cancer	0.000799	0.00768	CbGeAlD
Eletriptan—HTR1A—spinal cord—bone cancer	0.00069	0.00663	CbGeAlD
Eletriptan—PTGS1—connective tissue—bone cancer	0.000688	0.00661	CbGeAlD
Eletriptan—HTR7—tendon—bone cancer	0.000684	0.00657	CbGeAlD
Eletriptan—HTR7—spinal cord—bone cancer	0.00066	0.00634	CbGeAlD
Eletriptan—PTGS1—tendon—bone cancer	0.000473	0.00454	CbGeAlD
Eletriptan—PTGS1—spinal cord—bone cancer	0.000456	0.00438	CbGeAlD
Eletriptan—Erectile dysfunction—Methotrexate—bone cancer	0.000364	0.0018	CcSEcCtD
Eletriptan—Dry skin—Doxorubicin—bone cancer	0.000363	0.00179	CcSEcCtD
Eletriptan—Abdominal pain upper—Doxorubicin—bone cancer	0.000362	0.00179	CcSEcCtD
Eletriptan—Angina pectoris—Epirubicin—bone cancer	0.00036	0.00178	CcSEcCtD
Eletriptan—Decreased appetite—Cisplatin—bone cancer	0.000356	0.00176	CcSEcCtD
Eletriptan—Bronchitis—Epirubicin—bone cancer	0.000356	0.00176	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Cisplatin—bone cancer	0.000354	0.00175	CcSEcCtD
Eletriptan—Drowsiness—Methotrexate—bone cancer	0.000353	0.00174	CcSEcCtD
Eletriptan—Gastritis—Doxorubicin—bone cancer	0.000351	0.00173	CcSEcCtD
Eletriptan—Pain—Cisplatin—bone cancer	0.00035	0.00173	CcSEcCtD
Eletriptan—Muscular weakness—Doxorubicin—bone cancer	0.000349	0.00173	CcSEcCtD
Eletriptan—Abdominal distension—Doxorubicin—bone cancer	0.000345	0.0017	CcSEcCtD
Eletriptan—Stomatitis—Methotrexate—bone cancer	0.000344	0.0017	CcSEcCtD
Eletriptan—Conjunctivitis—Methotrexate—bone cancer	0.000343	0.00169	CcSEcCtD
Eletriptan—Dysphagia—Doxorubicin—bone cancer	0.000342	0.00169	CcSEcCtD
Eletriptan—Asthma—Doxorubicin—bone cancer	0.000342	0.00169	CcSEcCtD
Eletriptan—Influenza—Doxorubicin—bone cancer	0.000342	0.00169	CcSEcCtD
Eletriptan—Pollakiuria—Epirubicin—bone cancer	0.000342	0.00169	CcSEcCtD
Eletriptan—Sweating—Methotrexate—bone cancer	0.000338	0.00167	CcSEcCtD
Eletriptan—Feeling abnormal—Cisplatin—bone cancer	0.000338	0.00167	CcSEcCtD
Eletriptan—Weight increased—Epirubicin—bone cancer	0.000337	0.00166	CcSEcCtD
Eletriptan—Weight decreased—Epirubicin—bone cancer	0.000335	0.00165	CcSEcCtD
Eletriptan—Hyperglycaemia—Epirubicin—bone cancer	0.000334	0.00165	CcSEcCtD
Eletriptan—Angina pectoris—Doxorubicin—bone cancer	0.000333	0.00165	CcSEcCtD
Eletriptan—Epistaxis—Methotrexate—bone cancer	0.000333	0.00164	CcSEcCtD
Eletriptan—Drowsiness—Epirubicin—bone cancer	0.00033	0.00163	CcSEcCtD
Eletriptan—Bronchitis—Doxorubicin—bone cancer	0.000329	0.00163	CcSEcCtD
Eletriptan—Body temperature increased—Cisplatin—bone cancer	0.000324	0.0016	CcSEcCtD
Eletriptan—Neuropathy peripheral—Epirubicin—bone cancer	0.000323	0.0016	CcSEcCtD
Eletriptan—Stomatitis—Epirubicin—bone cancer	0.000322	0.00159	CcSEcCtD
Eletriptan—Conjunctivitis—Epirubicin—bone cancer	0.000321	0.00158	CcSEcCtD
Eletriptan—Sweating—Epirubicin—bone cancer	0.000316	0.00156	CcSEcCtD
Eletriptan—Pollakiuria—Doxorubicin—bone cancer	0.000316	0.00156	CcSEcCtD
Eletriptan—Pharyngitis—Methotrexate—bone cancer	0.000314	0.00155	CcSEcCtD
Eletriptan—Urinary tract disorder—Methotrexate—bone cancer	0.000313	0.00154	CcSEcCtD
Eletriptan—Weight increased—Doxorubicin—bone cancer	0.000312	0.00154	CcSEcCtD
Eletriptan—Epistaxis—Epirubicin—bone cancer	0.000311	0.00154	CcSEcCtD
Eletriptan—Urethral disorder—Methotrexate—bone cancer	0.00031	0.00153	CcSEcCtD
Eletriptan—Weight decreased—Doxorubicin—bone cancer	0.00031	0.00153	CcSEcCtD
Eletriptan—Sinusitis—Epirubicin—bone cancer	0.00031	0.00153	CcSEcCtD
Eletriptan—Hyperglycaemia—Doxorubicin—bone cancer	0.000309	0.00153	CcSEcCtD
Eletriptan—Drowsiness—Doxorubicin—bone cancer	0.000305	0.00151	CcSEcCtD
Eletriptan—Visual impairment—Methotrexate—bone cancer	0.000305	0.00151	CcSEcCtD
Eletriptan—Hypersensitivity—Cisplatin—bone cancer	0.000302	0.00149	CcSEcCtD
Eletriptan—Bradycardia—Epirubicin—bone cancer	0.000301	0.00149	CcSEcCtD
Eletriptan—Neuropathy peripheral—Doxorubicin—bone cancer	0.000299	0.00148	CcSEcCtD
Eletriptan—Stomatitis—Doxorubicin—bone cancer	0.000298	0.00147	CcSEcCtD
Eletriptan—Rhinitis—Epirubicin—bone cancer	0.000297	0.00147	CcSEcCtD
Eletriptan—Conjunctivitis—Doxorubicin—bone cancer	0.000297	0.00147	CcSEcCtD
Eletriptan—Tinnitus—Methotrexate—bone cancer	0.000295	0.00146	CcSEcCtD
Eletriptan—Hypoaesthesia—Epirubicin—bone cancer	0.000295	0.00146	CcSEcCtD
Eletriptan—Asthenia—Cisplatin—bone cancer	0.000294	0.00145	CcSEcCtD
Eletriptan—Pharyngitis—Epirubicin—bone cancer	0.000294	0.00145	CcSEcCtD
Eletriptan—Sweating—Doxorubicin—bone cancer	0.000293	0.00145	CcSEcCtD
Eletriptan—Urinary tract disorder—Epirubicin—bone cancer	0.000292	0.00145	CcSEcCtD
Eletriptan—Oedema peripheral—Epirubicin—bone cancer	0.000292	0.00144	CcSEcCtD
Eletriptan—Urethral disorder—Epirubicin—bone cancer	0.00029	0.00143	CcSEcCtD
Eletriptan—Epistaxis—Doxorubicin—bone cancer	0.000288	0.00142	CcSEcCtD
Eletriptan—Sinusitis—Doxorubicin—bone cancer	0.000286	0.00141	CcSEcCtD
Eletriptan—Immune system disorder—Methotrexate—bone cancer	0.000286	0.00141	CcSEcCtD
Eletriptan—Visual impairment—Epirubicin—bone cancer	0.000285	0.00141	CcSEcCtD
Eletriptan—Chills—Methotrexate—bone cancer	0.000284	0.0014	CcSEcCtD
Eletriptan—Diarrhoea—Cisplatin—bone cancer	0.00028	0.00139	CcSEcCtD
Eletriptan—Alopecia—Methotrexate—bone cancer	0.00028	0.00138	CcSEcCtD
Eletriptan—Bradycardia—Doxorubicin—bone cancer	0.000279	0.00138	CcSEcCtD
Eletriptan—Tinnitus—Epirubicin—bone cancer	0.000276	0.00136	CcSEcCtD
Eletriptan—Flushing—Epirubicin—bone cancer	0.000275	0.00136	CcSEcCtD
Eletriptan—Rhinitis—Doxorubicin—bone cancer	0.000275	0.00136	CcSEcCtD
Eletriptan—Hypoaesthesia—Doxorubicin—bone cancer	0.000273	0.00135	CcSEcCtD
Eletriptan—Pharyngitis—Doxorubicin—bone cancer	0.000272	0.00134	CcSEcCtD
Eletriptan—ABCB1—bone marrow—bone cancer	0.000271	0.0026	CbGeAlD
Eletriptan—Urinary tract disorder—Doxorubicin—bone cancer	0.000271	0.00134	CcSEcCtD
Eletriptan—Oedema peripheral—Doxorubicin—bone cancer	0.00027	0.00133	CcSEcCtD
Eletriptan—Dysgeusia—Methotrexate—bone cancer	0.00027	0.00133	CcSEcCtD
Eletriptan—ABCB1—spinal cord—bone cancer	0.00027	0.00259	CbGeAlD
Eletriptan—Urethral disorder—Doxorubicin—bone cancer	0.000269	0.00133	CcSEcCtD
Eletriptan—Immune system disorder—Epirubicin—bone cancer	0.000268	0.00132	CcSEcCtD
Eletriptan—Back pain—Methotrexate—bone cancer	0.000266	0.00132	CcSEcCtD
Eletriptan—Chills—Epirubicin—bone cancer	0.000266	0.00131	CcSEcCtD
Eletriptan—Arrhythmia—Epirubicin—bone cancer	0.000265	0.00131	CcSEcCtD
Eletriptan—Visual impairment—Doxorubicin—bone cancer	0.000264	0.0013	CcSEcCtD
Eletriptan—Alopecia—Epirubicin—bone cancer	0.000262	0.00129	CcSEcCtD
Eletriptan—Vomiting—Cisplatin—bone cancer	0.000261	0.00129	CcSEcCtD
Eletriptan—Rash—Cisplatin—bone cancer	0.000258	0.00128	CcSEcCtD
Eletriptan—Dermatitis—Cisplatin—bone cancer	0.000258	0.00128	CcSEcCtD
Eletriptan—Ill-defined disorder—Methotrexate—bone cancer	0.000256	0.00126	CcSEcCtD
Eletriptan—Tinnitus—Doxorubicin—bone cancer	0.000255	0.00126	CcSEcCtD
Eletriptan—Anaemia—Methotrexate—bone cancer	0.000255	0.00126	CcSEcCtD
Eletriptan—Flushing—Doxorubicin—bone cancer	0.000254	0.00126	CcSEcCtD
Eletriptan—Flatulence—Epirubicin—bone cancer	0.000254	0.00126	CcSEcCtD
Eletriptan—Tension—Epirubicin—bone cancer	0.000253	0.00125	CcSEcCtD
Eletriptan—Dysgeusia—Epirubicin—bone cancer	0.000252	0.00125	CcSEcCtD
Eletriptan—Nervousness—Epirubicin—bone cancer	0.00025	0.00124	CcSEcCtD
Eletriptan—Back pain—Epirubicin—bone cancer	0.000249	0.00123	CcSEcCtD
Eletriptan—Malaise—Methotrexate—bone cancer	0.000248	0.00123	CcSEcCtD
Eletriptan—Muscle spasms—Epirubicin—bone cancer	0.000248	0.00122	CcSEcCtD
Eletriptan—Immune system disorder—Doxorubicin—bone cancer	0.000248	0.00122	CcSEcCtD
Eletriptan—Vertigo—Methotrexate—bone cancer	0.000248	0.00122	CcSEcCtD
Eletriptan—Leukopenia—Methotrexate—bone cancer	0.000247	0.00122	CcSEcCtD
Eletriptan—Chills—Doxorubicin—bone cancer	0.000246	0.00121	CcSEcCtD
Eletriptan—Arrhythmia—Doxorubicin—bone cancer	0.000245	0.00121	CcSEcCtD
Eletriptan—Nausea—Cisplatin—bone cancer	0.000243	0.0012	CcSEcCtD
Eletriptan—Alopecia—Doxorubicin—bone cancer	0.000242	0.0012	CcSEcCtD
Eletriptan—Cough—Methotrexate—bone cancer	0.00024	0.00119	CcSEcCtD
Eletriptan—Ill-defined disorder—Epirubicin—bone cancer	0.000239	0.00118	CcSEcCtD
Eletriptan—Convulsion—Methotrexate—bone cancer	0.000239	0.00118	CcSEcCtD
Eletriptan—Anaemia—Epirubicin—bone cancer	0.000238	0.00118	CcSEcCtD
Eletriptan—Agitation—Epirubicin—bone cancer	0.000237	0.00117	CcSEcCtD
Eletriptan—Flatulence—Doxorubicin—bone cancer	0.000235	0.00116	CcSEcCtD
Eletriptan—Arthralgia—Methotrexate—bone cancer	0.000235	0.00116	CcSEcCtD
Eletriptan—Myalgia—Methotrexate—bone cancer	0.000235	0.00116	CcSEcCtD
Eletriptan—Tension—Doxorubicin—bone cancer	0.000234	0.00116	CcSEcCtD
Eletriptan—Dysgeusia—Doxorubicin—bone cancer	0.000234	0.00115	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000233	0.00115	CcSEcCtD
Eletriptan—Malaise—Epirubicin—bone cancer	0.000232	0.00115	CcSEcCtD
Eletriptan—Discomfort—Methotrexate—bone cancer	0.000232	0.00114	CcSEcCtD
Eletriptan—Nervousness—Doxorubicin—bone cancer	0.000232	0.00114	CcSEcCtD
Eletriptan—Vertigo—Epirubicin—bone cancer	0.000232	0.00114	CcSEcCtD
Eletriptan—Syncope—Epirubicin—bone cancer	0.000231	0.00114	CcSEcCtD
Eletriptan—Leukopenia—Epirubicin—bone cancer	0.000231	0.00114	CcSEcCtD
Eletriptan—Back pain—Doxorubicin—bone cancer	0.000231	0.00114	CcSEcCtD
Eletriptan—Muscle spasms—Doxorubicin—bone cancer	0.000229	0.00113	CcSEcCtD
Eletriptan—Palpitations—Epirubicin—bone cancer	0.000228	0.00113	CcSEcCtD
Eletriptan—Confusional state—Methotrexate—bone cancer	0.000227	0.00112	CcSEcCtD
Eletriptan—Loss of consciousness—Epirubicin—bone cancer	0.000227	0.00112	CcSEcCtD
Eletriptan—Cough—Epirubicin—bone cancer	0.000225	0.00111	CcSEcCtD
Eletriptan—Convulsion—Epirubicin—bone cancer	0.000223	0.0011	CcSEcCtD
Eletriptan—Hypertension—Epirubicin—bone cancer	0.000223	0.0011	CcSEcCtD
Eletriptan—Ill-defined disorder—Doxorubicin—bone cancer	0.000221	0.00109	CcSEcCtD
Eletriptan—Nervous system disorder—Methotrexate—bone cancer	0.00022	0.00109	CcSEcCtD
Eletriptan—Anaemia—Doxorubicin—bone cancer	0.00022	0.00109	CcSEcCtD
Eletriptan—Arthralgia—Epirubicin—bone cancer	0.000219	0.00108	CcSEcCtD
Eletriptan—Myalgia—Epirubicin—bone cancer	0.000219	0.00108	CcSEcCtD
Eletriptan—Agitation—Doxorubicin—bone cancer	0.000219	0.00108	CcSEcCtD
Eletriptan—Anxiety—Epirubicin—bone cancer	0.000219	0.00108	CcSEcCtD
Eletriptan—Skin disorder—Methotrexate—bone cancer	0.000218	0.00108	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000218	0.00108	CcSEcCtD
Eletriptan—Hyperhidrosis—Methotrexate—bone cancer	0.000217	0.00107	CcSEcCtD
Eletriptan—Discomfort—Epirubicin—bone cancer	0.000217	0.00107	CcSEcCtD
Eletriptan—Malaise—Doxorubicin—bone cancer	0.000215	0.00106	CcSEcCtD
Eletriptan—Dry mouth—Epirubicin—bone cancer	0.000215	0.00106	CcSEcCtD
Eletriptan—Vertigo—Doxorubicin—bone cancer	0.000214	0.00106	CcSEcCtD
Eletriptan—Anorexia—Methotrexate—bone cancer	0.000214	0.00106	CcSEcCtD
Eletriptan—Syncope—Doxorubicin—bone cancer	0.000214	0.00106	CcSEcCtD
Eletriptan—Leukopenia—Doxorubicin—bone cancer	0.000214	0.00106	CcSEcCtD
Eletriptan—Confusional state—Epirubicin—bone cancer	0.000212	0.00105	CcSEcCtD
Eletriptan—Palpitations—Doxorubicin—bone cancer	0.000211	0.00104	CcSEcCtD
Eletriptan—Oedema—Epirubicin—bone cancer	0.00021	0.00104	CcSEcCtD
Eletriptan—Hypotension—Methotrexate—bone cancer	0.00021	0.00104	CcSEcCtD
Eletriptan—Loss of consciousness—Doxorubicin—bone cancer	0.00021	0.00104	CcSEcCtD
Eletriptan—Cough—Doxorubicin—bone cancer	0.000208	0.00103	CcSEcCtD
Eletriptan—Shock—Epirubicin—bone cancer	0.000207	0.00102	CcSEcCtD
Eletriptan—Convulsion—Doxorubicin—bone cancer	0.000207	0.00102	CcSEcCtD
Eletriptan—Nervous system disorder—Epirubicin—bone cancer	0.000206	0.00102	CcSEcCtD
Eletriptan—Hypertension—Doxorubicin—bone cancer	0.000206	0.00102	CcSEcCtD
Eletriptan—Tachycardia—Epirubicin—bone cancer	0.000205	0.00101	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000205	0.00101	CcSEcCtD
Eletriptan—Skin disorder—Epirubicin—bone cancer	0.000204	0.00101	CcSEcCtD
Eletriptan—Hyperhidrosis—Epirubicin—bone cancer	0.000203	0.00101	CcSEcCtD
Eletriptan—Insomnia—Methotrexate—bone cancer	0.000203	0.001	CcSEcCtD
Eletriptan—Myalgia—Doxorubicin—bone cancer	0.000203	0.001	CcSEcCtD
Eletriptan—Arthralgia—Doxorubicin—bone cancer	0.000203	0.001	CcSEcCtD
Eletriptan—Anxiety—Doxorubicin—bone cancer	0.000202	0.001	CcSEcCtD
Eletriptan—Paraesthesia—Methotrexate—bone cancer	0.000202	0.000998	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000202	0.000997	CcSEcCtD
Eletriptan—Discomfort—Doxorubicin—bone cancer	0.000201	0.000991	CcSEcCtD
Eletriptan—Anorexia—Epirubicin—bone cancer	0.000201	0.000991	CcSEcCtD
Eletriptan—Dyspnoea—Methotrexate—bone cancer	0.0002	0.00099	CcSEcCtD
Eletriptan—Somnolence—Methotrexate—bone cancer	0.0002	0.000988	CcSEcCtD
Eletriptan—Dry mouth—Doxorubicin—bone cancer	0.000199	0.000981	CcSEcCtD
Eletriptan—Dyspepsia—Methotrexate—bone cancer	0.000198	0.000978	CcSEcCtD
Eletriptan—Hypotension—Epirubicin—bone cancer	0.000197	0.000971	CcSEcCtD
Eletriptan—Confusional state—Doxorubicin—bone cancer	0.000196	0.00097	CcSEcCtD
Eletriptan—Decreased appetite—Methotrexate—bone cancer	0.000195	0.000966	CcSEcCtD
Eletriptan—Oedema—Doxorubicin—bone cancer	0.000195	0.000962	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Methotrexate—bone cancer	0.000194	0.000959	CcSEcCtD
Eletriptan—Fatigue—Methotrexate—bone cancer	0.000194	0.000958	CcSEcCtD
Eletriptan—Pain—Methotrexate—bone cancer	0.000192	0.00095	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000192	0.000947	CcSEcCtD
Eletriptan—Shock—Doxorubicin—bone cancer	0.000192	0.000946	CcSEcCtD
Eletriptan—Nervous system disorder—Doxorubicin—bone cancer	0.000191	0.000943	CcSEcCtD
Eletriptan—Insomnia—Epirubicin—bone cancer	0.00019	0.00094	CcSEcCtD
Eletriptan—Tachycardia—Doxorubicin—bone cancer	0.00019	0.000939	CcSEcCtD
Eletriptan—Skin disorder—Doxorubicin—bone cancer	0.000189	0.000934	CcSEcCtD
Eletriptan—Paraesthesia—Epirubicin—bone cancer	0.000189	0.000934	CcSEcCtD
Eletriptan—Hyperhidrosis—Doxorubicin—bone cancer	0.000188	0.00093	CcSEcCtD
Eletriptan—Dyspnoea—Epirubicin—bone cancer	0.000188	0.000927	CcSEcCtD
Eletriptan—Somnolence—Epirubicin—bone cancer	0.000187	0.000924	CcSEcCtD
Eletriptan—Anorexia—Doxorubicin—bone cancer	0.000186	0.000917	CcSEcCtD
Eletriptan—Feeling abnormal—Methotrexate—bone cancer	0.000185	0.000915	CcSEcCtD
Eletriptan—Dyspepsia—Epirubicin—bone cancer	0.000185	0.000915	CcSEcCtD
Eletriptan—Gastrointestinal pain—Methotrexate—bone cancer	0.000184	0.000908	CcSEcCtD
Eletriptan—Decreased appetite—Epirubicin—bone cancer	0.000183	0.000904	CcSEcCtD
Eletriptan—Hypotension—Doxorubicin—bone cancer	0.000182	0.000899	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Epirubicin—bone cancer	0.000182	0.000898	CcSEcCtD
Eletriptan—Fatigue—Epirubicin—bone cancer	0.000181	0.000896	CcSEcCtD
Eletriptan—Pain—Epirubicin—bone cancer	0.00018	0.000889	CcSEcCtD
Eletriptan—Constipation—Epirubicin—bone cancer	0.00018	0.000889	CcSEcCtD
Eletriptan—Urticaria—Methotrexate—bone cancer	0.000179	0.000883	CcSEcCtD
Eletriptan—Abdominal pain—Methotrexate—bone cancer	0.000178	0.000878	CcSEcCtD
Eletriptan—Body temperature increased—Methotrexate—bone cancer	0.000178	0.000878	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000177	0.000876	CcSEcCtD
Eletriptan—Insomnia—Doxorubicin—bone cancer	0.000176	0.00087	CcSEcCtD
Eletriptan—Paraesthesia—Doxorubicin—bone cancer	0.000175	0.000864	CcSEcCtD
Eletriptan—Dyspnoea—Doxorubicin—bone cancer	0.000174	0.000858	CcSEcCtD
Eletriptan—Feeling abnormal—Epirubicin—bone cancer	0.000173	0.000857	CcSEcCtD
Eletriptan—Somnolence—Doxorubicin—bone cancer	0.000173	0.000855	CcSEcCtD
Eletriptan—Gastrointestinal pain—Epirubicin—bone cancer	0.000172	0.00085	CcSEcCtD
Eletriptan—Dyspepsia—Doxorubicin—bone cancer	0.000171	0.000847	CcSEcCtD
Eletriptan—Decreased appetite—Doxorubicin—bone cancer	0.000169	0.000836	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000168	0.00083	CcSEcCtD
Eletriptan—Fatigue—Doxorubicin—bone cancer	0.000168	0.000829	CcSEcCtD
Eletriptan—Urticaria—Epirubicin—bone cancer	0.000167	0.000826	CcSEcCtD
Eletriptan—Pain—Doxorubicin—bone cancer	0.000166	0.000823	CcSEcCtD
Eletriptan—Constipation—Doxorubicin—bone cancer	0.000166	0.000823	CcSEcCtD
Eletriptan—Abdominal pain—Epirubicin—bone cancer	0.000166	0.000822	CcSEcCtD
Eletriptan—Body temperature increased—Epirubicin—bone cancer	0.000166	0.000822	CcSEcCtD
Eletriptan—Hypersensitivity—Methotrexate—bone cancer	0.000166	0.000818	CcSEcCtD
Eletriptan—Asthenia—Methotrexate—bone cancer	0.000161	0.000797	CcSEcCtD
Eletriptan—Feeling abnormal—Doxorubicin—bone cancer	0.00016	0.000793	CcSEcCtD
Eletriptan—Gastrointestinal pain—Doxorubicin—bone cancer	0.000159	0.000787	CcSEcCtD
Eletriptan—Pruritus—Methotrexate—bone cancer	0.000159	0.000786	CcSEcCtD
Eletriptan—Hypersensitivity—Epirubicin—bone cancer	0.000155	0.000766	CcSEcCtD
Eletriptan—Urticaria—Doxorubicin—bone cancer	0.000155	0.000764	CcSEcCtD
Eletriptan—Abdominal pain—Doxorubicin—bone cancer	0.000154	0.00076	CcSEcCtD
Eletriptan—Body temperature increased—Doxorubicin—bone cancer	0.000154	0.00076	CcSEcCtD
Eletriptan—Diarrhoea—Methotrexate—bone cancer	0.000154	0.00076	CcSEcCtD
Eletriptan—Asthenia—Epirubicin—bone cancer	0.000151	0.000746	CcSEcCtD
Eletriptan—Pruritus—Epirubicin—bone cancer	0.000149	0.000736	CcSEcCtD
Eletriptan—Dizziness—Methotrexate—bone cancer	0.000149	0.000735	CcSEcCtD
Eletriptan—Diarrhoea—Epirubicin—bone cancer	0.000144	0.000711	CcSEcCtD
Eletriptan—Hypersensitivity—Doxorubicin—bone cancer	0.000143	0.000709	CcSEcCtD
Eletriptan—Vomiting—Methotrexate—bone cancer	0.000143	0.000706	CcSEcCtD
Eletriptan—Rash—Methotrexate—bone cancer	0.000142	0.0007	CcSEcCtD
Eletriptan—Dermatitis—Methotrexate—bone cancer	0.000142	0.0007	CcSEcCtD
Eletriptan—Headache—Methotrexate—bone cancer	0.000141	0.000696	CcSEcCtD
Eletriptan—Asthenia—Doxorubicin—bone cancer	0.00014	0.00069	CcSEcCtD
Eletriptan—Dizziness—Epirubicin—bone cancer	0.000139	0.000687	CcSEcCtD
Eletriptan—Pruritus—Doxorubicin—bone cancer	0.000138	0.000681	CcSEcCtD
Eletriptan—Vomiting—Epirubicin—bone cancer	0.000134	0.000661	CcSEcCtD
Eletriptan—Nausea—Methotrexate—bone cancer	0.000134	0.00066	CcSEcCtD
Eletriptan—Diarrhoea—Doxorubicin—bone cancer	0.000133	0.000658	CcSEcCtD
Eletriptan—Rash—Epirubicin—bone cancer	0.000133	0.000655	CcSEcCtD
Eletriptan—Dermatitis—Epirubicin—bone cancer	0.000133	0.000655	CcSEcCtD
Eletriptan—Headache—Epirubicin—bone cancer	0.000132	0.000651	CcSEcCtD
Eletriptan—Dizziness—Doxorubicin—bone cancer	0.000129	0.000636	CcSEcCtD
Eletriptan—Nausea—Epirubicin—bone cancer	0.000125	0.000618	CcSEcCtD
Eletriptan—Vomiting—Doxorubicin—bone cancer	0.000124	0.000612	CcSEcCtD
Eletriptan—Rash—Doxorubicin—bone cancer	0.000123	0.000607	CcSEcCtD
Eletriptan—Dermatitis—Doxorubicin—bone cancer	0.000123	0.000606	CcSEcCtD
Eletriptan—Headache—Doxorubicin—bone cancer	0.000122	0.000603	CcSEcCtD
Eletriptan—Nausea—Doxorubicin—bone cancer	0.000116	0.000571	CcSEcCtD
Eletriptan—HTR1E—Signaling by GPCR—SMO—bone cancer	0.000105	0.00156	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—SMO—bone cancer	0.000103	0.00154	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—GRM1—bone cancer	0.000102	0.00152	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—GNA11—bone cancer	0.000101	0.00151	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—GRM1—bone cancer	0.000101	0.00151	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—IL3—bone cancer	0.000101	0.00151	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—RGS1—bone cancer	0.000101	0.00151	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—GRM4—bone cancer	0.000101	0.00151	CbGpPWpGaD
Eletriptan—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000101	0.0015	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—GRM1—bone cancer	0.000101	0.0015	CbGpPWpGaD
Eletriptan—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	9.94e-05	0.00148	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	9.94e-05	0.00148	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—NDUFA12—bone cancer	9.91e-05	0.00148	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—GRM1—bone cancer	9.85e-05	0.00147	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—GNA11—bone cancer	9.56e-05	0.00143	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—IL3—bone cancer	9.55e-05	0.00142	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—RGS1—bone cancer	9.53e-05	0.00142	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—GRM4—bone cancer	9.53e-05	0.00142	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—GRM1—bone cancer	9.29e-05	0.00139	CbGpPWpGaD
Eletriptan—CYP2D6—Biological oxidations—CYP3A4—bone cancer	9.27e-05	0.00138	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—GRM1—bone cancer	9.25e-05	0.00138	CbGpPWpGaD
Eletriptan—CYP2C9—Biological oxidations—CYP3A4—bone cancer	9.19e-05	0.00137	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—IL3—bone cancer	9.19e-05	0.00137	CbGpPWpGaD
Eletriptan—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	9.15e-05	0.00136	CbGpPWpGaD
Eletriptan—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	9.07e-05	0.00135	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	9.05e-05	0.00135	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	8.93e-05	0.00133	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—GRM1—bone cancer	8.76e-05	0.00131	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—NT5C3A—bone cancer	8.69e-05	0.0013	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—IL3—bone cancer	8.67e-05	0.00129	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—RGS1—bone cancer	8.65e-05	0.00129	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—GRM4—bone cancer	8.65e-05	0.00129	CbGpPWpGaD
Eletriptan—CYP2C19—Biological oxidations—GSTP1—bone cancer	8.62e-05	0.00129	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—JUN—bone cancer	8.62e-05	0.00129	CbGpPWpGaD
Eletriptan—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	8.5e-05	0.00127	CbGpPWpGaD
Eletriptan—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	8.46e-05	0.00126	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—GRM1—bone cancer	8.26e-05	0.00123	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—NT5C3A—bone cancer	8.21e-05	0.00123	CbGpPWpGaD
Eletriptan—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8e-05	0.00119	CbGpPWpGaD
Eletriptan—CYP2D6—Biological oxidations—GSTP1—bone cancer	7.93e-05	0.00118	CbGpPWpGaD
Eletriptan—CYP2C9—Biological oxidations—GSTP1—bone cancer	7.86e-05	0.00117	CbGpPWpGaD
Eletriptan—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	7.82e-05	0.00117	CbGpPWpGaD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—JUN—bone cancer	7.82e-05	0.00117	CbGpPWpGaD
Eletriptan—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	7.75e-05	0.00116	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.56e-05	0.00113	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.54e-05	0.00113	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—GRM1—bone cancer	7.5e-05	0.00112	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—GNA11—bone cancer	7.18e-05	0.00107	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—GNA11—bone cancer	7.14e-05	0.00107	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—SMO—bone cancer	7.13e-05	0.00106	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—SMO—bone cancer	7.09e-05	0.00106	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—GNA11—bone cancer	6.99e-05	0.00104	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—SMO—bone cancer	6.94e-05	0.00104	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—GRM4—bone cancer	6.9e-05	0.00103	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—RGS1—bone cancer	6.9e-05	0.00103	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—GRM4—bone cancer	6.85e-05	0.00102	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—RGS1—bone cancer	6.85e-05	0.00102	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—RGS1—bone cancer	6.71e-05	0.001	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—GRM4—bone cancer	6.71e-05	0.001	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—GNA11—bone cancer	6.57e-05	0.00098	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—SMO—bone cancer	6.55e-05	0.000977	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—GNA11—bone cancer	6.52e-05	0.000974	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—SMO—bone cancer	6.52e-05	0.000973	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—IL3—bone cancer	6.51e-05	0.000972	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.51e-05	0.000972	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—GNA11—bone cancer	6.48e-05	0.000967	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—IL3—bone cancer	6.47e-05	0.000966	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—GNA11—bone cancer	6.35e-05	0.000947	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—IL3—bone cancer	6.34e-05	0.000946	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—RGS1—bone cancer	6.3e-05	0.000941	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—GRM4—bone cancer	6.3e-05	0.000941	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—SMO—bone cancer	6.18e-05	0.000922	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—NDUFA12—bone cancer	6.04e-05	0.000902	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—GNA11—bone cancer	5.99e-05	0.000894	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—GRM1—bone cancer	5.98e-05	0.000893	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—GNA11—bone cancer	5.96e-05	0.00089	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—IL3—bone cancer	5.95e-05	0.000888	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—GRM1—bone cancer	5.94e-05	0.000887	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL3—bone cancer	5.91e-05	0.000883	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—NDUFA12—bone cancer	5.9e-05	0.00088	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL3—bone cancer	5.88e-05	0.000877	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	5.87e-05	0.000876	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—GRM1—bone cancer	5.82e-05	0.000868	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL3—bone cancer	5.75e-05	0.000859	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—TP53—bone cancer	5.69e-05	0.000849	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—GNA11—bone cancer	5.65e-05	0.000843	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.61e-05	0.000837	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—ATF1—bone cancer	5.57e-05	0.000831	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—NDUFA12—bone cancer	5.56e-05	0.00083	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—NDUFA12—bone cancer	5.51e-05	0.000822	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—GRM1—bone cancer	5.47e-05	0.000816	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL3—bone cancer	5.43e-05	0.00081	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL3—bone cancer	5.4e-05	0.000807	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—GNA11—bone cancer	5.32e-05	0.000795	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—SMO—bone cancer	5.29e-05	0.000789	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—ATF1—bone cancer	5.25e-05	0.000784	CbGpPWpGaD
Eletriptan—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.19e-05	0.000774	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL3—bone cancer	5.12e-05	0.000764	CbGpPWpGaD
Eletriptan—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.11e-05	0.000763	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—GRM4—bone cancer	5.11e-05	0.000763	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RGS1—bone cancer	5.11e-05	0.000763	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—NT5C3A—bone cancer	5.01e-05	0.000747	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—NT5C3A—bone cancer	4.89e-05	0.000729	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—GNA11—bone cancer	4.83e-05	0.000722	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—IL3—bone cancer	4.83e-05	0.00072	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TGFBR2—bone cancer	4.64e-05	0.000693	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—NT5C3A—bone cancer	4.61e-05	0.000687	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—NT5C3A—bone cancer	4.57e-05	0.000681	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—GRM1—bone cancer	4.43e-05	0.000661	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL3—bone cancer	4.38e-05	0.000654	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TGFBR2—bone cancer	4.38e-05	0.000654	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IGF1R—bone cancer	4.37e-05	0.000652	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SMO—bone cancer	4.21e-05	0.000629	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SMO—bone cancer	4.19e-05	0.000625	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.16e-05	0.000621	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IGF1R—bone cancer	4.12e-05	0.000615	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SMO—bone cancer	4.1e-05	0.000612	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.01e-05	0.000598	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—GNA11—bone cancer	3.85e-05	0.000575	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SMO—bone cancer	3.85e-05	0.000575	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—GNA11—bone cancer	3.83e-05	0.000571	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ENO2—bone cancer	3.8e-05	0.000568	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—GNA11—bone cancer	3.75e-05	0.00056	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NDUFA12—bone cancer	3.63e-05	0.000542	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.62e-05	0.00054	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ENO2—bone cancer	3.6e-05	0.000537	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ATF1—bone cancer	3.58e-05	0.000535	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ATF1—bone cancer	3.56e-05	0.000531	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—DHFR—bone cancer	3.53e-05	0.000527	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—GNA11—bone cancer	3.52e-05	0.000526	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL3—bone cancer	3.49e-05	0.000521	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ATF1—bone cancer	3.49e-05	0.00052	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL3—bone cancer	3.47e-05	0.000518	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL3—bone cancer	3.4e-05	0.000507	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—DHFR—bone cancer	3.34e-05	0.000498	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GNA11—bone cancer	3.3e-05	0.000492	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ATF1—bone cancer	3.27e-05	0.000489	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL3—bone cancer	3.19e-05	0.000476	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—KIT—bone cancer	3.17e-05	0.000473	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SMO—bone cancer	3.12e-05	0.000466	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GNA11—bone cancer	3.12e-05	0.000466	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NT5C3A—bone cancer	3.01e-05	0.000449	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CYP3A4—bone cancer	2.99e-05	0.000446	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—KIT—bone cancer	2.99e-05	0.000446	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TGFBR2—bone cancer	2.99e-05	0.000446	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—BRAF—bone cancer	2.98e-05	0.000444	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.98e-05	0.000444	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TGFBR2—bone cancer	2.97e-05	0.000443	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TGFBR2—bone cancer	2.91e-05	0.000434	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—EGFR—bone cancer	2.89e-05	0.000431	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—GNA11—bone cancer	2.86e-05	0.000426	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.84e-05	0.000424	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CYP3A4—bone cancer	2.83e-05	0.000422	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IGF1R—bone cancer	2.81e-05	0.00042	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—BRAF—bone cancer	2.81e-05	0.000419	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IGF1R—bone cancer	2.79e-05	0.000417	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IGF1R—bone cancer	2.73e-05	0.000408	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TGFBR2—bone cancer	2.73e-05	0.000408	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—EGFR—bone cancer	2.72e-05	0.000406	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ATF1—bone cancer	2.66e-05	0.000396	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL3—bone cancer	2.59e-05	0.000386	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IGF1R—bone cancer	2.57e-05	0.000383	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GSTP1—bone cancer	2.56e-05	0.000382	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MDM2—bone cancer	2.49e-05	0.000372	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GSTP1—bone cancer	2.42e-05	0.000361	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.39e-05	0.000356	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MDM2—bone cancer	2.35e-05	0.000351	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TGFBR2—bone cancer	2.21e-05	0.00033	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ENO2—bone cancer	2.19e-05	0.000327	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—JUN—bone cancer	2.17e-05	0.000324	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ENO2—bone cancer	2.14e-05	0.00032	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MMP9—bone cancer	2.11e-05	0.000315	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IGF1R—bone cancer	2.08e-05	0.000311	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—JUN—bone cancer	2.05e-05	0.000305	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—KIT—bone cancer	2.04e-05	0.000304	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—DHFR—bone cancer	2.03e-05	0.000304	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—KIT—bone cancer	2.03e-05	0.000302	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ENO2—bone cancer	2.02e-05	0.000301	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ENO2—bone cancer	2e-05	0.000298	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MMP9—bone cancer	1.99e-05	0.000297	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—DHFR—bone cancer	1.99e-05	0.000296	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—KIT—bone cancer	1.98e-05	0.000296	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—BRAF—bone cancer	1.92e-05	0.000286	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—BRAF—bone cancer	1.9e-05	0.000284	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GNA11—bone cancer	1.9e-05	0.000284	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—DHFR—bone cancer	1.87e-05	0.000279	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—BRAF—bone cancer	1.86e-05	0.000278	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—KIT—bone cancer	1.86e-05	0.000278	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—EGFR—bone cancer	1.86e-05	0.000277	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GNA11—bone cancer	1.86e-05	0.000277	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—DHFR—bone cancer	1.86e-05	0.000277	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—EGFR—bone cancer	1.85e-05	0.000275	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—EGFR—bone cancer	1.81e-05	0.00027	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—BRAF—bone cancer	1.75e-05	0.000261	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GNA11—bone cancer	1.75e-05	0.000261	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GNA11—bone cancer	1.73e-05	0.000259	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP3A4—bone cancer	1.72e-05	0.000257	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.72e-05	0.000256	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—EGFR—bone cancer	1.7e-05	0.000254	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—EGFR—bone cancer	1.7e-05	0.000253	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP3A4—bone cancer	1.68e-05	0.000251	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—EGFR—bone cancer	1.61e-05	0.00024	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MDM2—bone cancer	1.61e-05	0.00024	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MDM2—bone cancer	1.6e-05	0.000238	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP3A4—bone cancer	1.59e-05	0.000237	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP3A4—bone cancer	1.57e-05	0.000235	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.56e-05	0.000233	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MDM2—bone cancer	1.56e-05	0.000233	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KIT—bone cancer	1.51e-05	0.000226	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GSTP1—bone cancer	1.47e-05	0.00022	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MDM2—bone cancer	1.47e-05	0.000219	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTP1—bone cancer	1.44e-05	0.000215	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TP53—bone cancer	1.43e-05	0.000214	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—BRAF—bone cancer	1.42e-05	0.000212	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—JUN—bone cancer	1.4e-05	0.000208	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—JUN—bone cancer	1.39e-05	0.000207	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.38e-05	0.000205	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MMP9—bone cancer	1.36e-05	0.000203	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—JUN—bone cancer	1.36e-05	0.000203	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTP1—bone cancer	1.36e-05	0.000202	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TP53—bone cancer	1.35e-05	0.000202	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MMP9—bone cancer	1.35e-05	0.000201	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTP1—bone cancer	1.34e-05	0.000201	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTGS2—bone cancer	1.33e-05	0.000198	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MMP9—bone cancer	1.32e-05	0.000197	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ENO2—bone cancer	1.32e-05	0.000197	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—JUN—bone cancer	1.28e-05	0.00019	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTGS2—bone cancer	1.25e-05	0.000187	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MMP9—bone cancer	1.24e-05	0.000185	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—DHFR—bone cancer	1.22e-05	0.000183	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MDM2—bone cancer	1.19e-05	0.000178	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GNA11—bone cancer	1.14e-05	0.000171	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EGFR—bone cancer	1.1e-05	0.000164	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EGFR—bone cancer	1.09e-05	0.000163	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EGFR—bone cancer	1.07e-05	0.000159	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—JUN—bone cancer	1.03e-05	0.000154	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MMP9—bone cancer	1.01e-05	0.00015	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EGFR—bone cancer	1e-05	0.00015	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TP53—bone cancer	9.21e-06	0.000138	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TP53—bone cancer	9.15e-06	0.000137	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TP53—bone cancer	8.96e-06	0.000134	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTP1—bone cancer	8.87e-06	0.000132	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TP53—bone cancer	8.42e-06	0.000126	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EGFR—bone cancer	8.13e-06	0.000121	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTGS2—bone cancer	7.64e-06	0.000114	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTGS2—bone cancer	7.46e-06	0.000111	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTGS2—bone cancer	7.03e-06	0.000105	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTGS2—bone cancer	6.97e-06	0.000104	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TP53—bone cancer	6.83e-06	0.000102	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS2—bone cancer	4.59e-06	6.86e-05	CbGpPWpGaD
